Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population
-
- K Hambardzumyan
- Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
-
- C Hermanrud
- Clinical Neuroimmunology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
-
- P Marits
- Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden
-
- N Vivar
- Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
-
- S Ernestam
- Academic Specialist Centre, Stockholm Health Services, Stockholm, Sweden
-
- JK Wallman
- Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden
-
- RF van Vollenhoven
- Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
-
- A Fogdell-Hahn
- Clinical Neuroimmunology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
-
- S Saevarsdottir
- Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
収録刊行物
-
- Scandinavian Journal of Rheumatology
-
Scandinavian Journal of Rheumatology 48 (5), 362-366, 2019-06-27
Informa UK Limited